Convergent downstream candidate mechanisms of independent intergenic polymorphisms between co-classified diseases implicate epistasis among noncoding elements

Jiali Han, Jianrong Li, Ikbel Achour, Lorenzo Pesce, Ian Foster, Haiquan Li, Yves A Lussier

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

Eighty percent of DNA outside protein coding regions was shown biochemically functional by the ENCODE project, enabling studies of their interactions. Studies have since explored how convergent downstream mechanisms arise from independent genetic risks of one complex disease. However, the cross-talk and epistasis between intergenic risks associated with distinct complex diseases have not been comprehensively characterized. Our recent integrative genomic analysis unveiled downstream biological effectors of disease-specific polymorphisms buried in intergenic regions, and we then validated their genetic synergy and antagonism in distinct GWAS. We extend this approach to characterize convergent downstream candidate mechanisms of distinct intergenic SNPs across distinct diseases within the same clinical classification. We construct a multipartite network consisting of 467 diseases organized in 15 classes, 2,358 disease-associated SNPs, 6,301 SNP-associated mRNAs by eQTL, and mRNA annotations to 4,538 Gene Ontology mechanisms. Functional similarity between two SNPs (similar SNP pairs) is imputed using a nested information theoretic distance model for which p-values are assigned by conservative scale-free permutation of network edges without replacement (node degrees constant). At FDR≤5%, we prioritized 3,870 intergenic SNP pairs associated, among which 755 are associated with distinct diseases sharing the same disease class, implicating 167 intergenic SNPs, 14 classes, 230 mRNAs, and 134 GO terms. Co-classified SNP pairs were more likely to be prioritized as compared to those of distinct classes confirming a noncoding genetic underpinning to clinical classification (odds ratio ~3.8; p≤10-25). The prioritized pairs were also enriched in regions bound to the same/interacting transcription factors and/or interacting in long-range chromatin interactions suggestive of epistasis (odds ratio ~ 2,500; p≤10-25). This prioritized network implicates complex epistasis between intergenic polymorphisms of co-classified diseases and offers a roadmap for a novel therapeutic paradigm: repositioning medications that target proteins within downstream mechanisms of intergenic disease-associated SNPs.

Original languageEnglish (US)
Title of host publicationPACIFIC SYMPOSIUM ON BIOCOMPUTING 2018
PublisherWorld Scientific Publishing Co. Pte Ltd
Pages524-535
Number of pages12
Edition212669
ISBN (Print)9789813235533
DOIs
StatePublished - Jan 1 2018
Event23rd Pacific Symposium on Biocomputing, PSB 2018 - Kohala Coast, United States
Duration: Jan 3 2018Jan 7 2018

Other

Other23rd Pacific Symposium on Biocomputing, PSB 2018
CountryUnited States
CityKohala Coast
Period1/3/181/7/18

Fingerprint

Polymorphism
Proteins
Transcription factors
Complex networks
Ontology
DNA
Genes

Keywords

  • Biological similarity
  • Disease class
  • Enrichment
  • Intergenic
  • Noncoding
  • SNP

ASJC Scopus subject areas

  • Biomedical Engineering
  • Computational Theory and Mathematics

Cite this

Han, J., Li, J., Achour, I., Pesce, L., Foster, I., Li, H., & Lussier, Y. A. (2018). Convergent downstream candidate mechanisms of independent intergenic polymorphisms between co-classified diseases implicate epistasis among noncoding elements. In PACIFIC SYMPOSIUM ON BIOCOMPUTING 2018 (212669 ed., pp. 524-535). World Scientific Publishing Co. Pte Ltd. https://doi.org/10.1142/9789813235533_0048

Convergent downstream candidate mechanisms of independent intergenic polymorphisms between co-classified diseases implicate epistasis among noncoding elements. / Han, Jiali; Li, Jianrong; Achour, Ikbel; Pesce, Lorenzo; Foster, Ian; Li, Haiquan; Lussier, Yves A.

PACIFIC SYMPOSIUM ON BIOCOMPUTING 2018. 212669. ed. World Scientific Publishing Co. Pte Ltd, 2018. p. 524-535.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Han, J, Li, J, Achour, I, Pesce, L, Foster, I, Li, H & Lussier, YA 2018, Convergent downstream candidate mechanisms of independent intergenic polymorphisms between co-classified diseases implicate epistasis among noncoding elements. in PACIFIC SYMPOSIUM ON BIOCOMPUTING 2018. 212669 edn, World Scientific Publishing Co. Pte Ltd, pp. 524-535, 23rd Pacific Symposium on Biocomputing, PSB 2018, Kohala Coast, United States, 1/3/18. https://doi.org/10.1142/9789813235533_0048
Han J, Li J, Achour I, Pesce L, Foster I, Li H et al. Convergent downstream candidate mechanisms of independent intergenic polymorphisms between co-classified diseases implicate epistasis among noncoding elements. In PACIFIC SYMPOSIUM ON BIOCOMPUTING 2018. 212669 ed. World Scientific Publishing Co. Pte Ltd. 2018. p. 524-535 https://doi.org/10.1142/9789813235533_0048
Han, Jiali ; Li, Jianrong ; Achour, Ikbel ; Pesce, Lorenzo ; Foster, Ian ; Li, Haiquan ; Lussier, Yves A. / Convergent downstream candidate mechanisms of independent intergenic polymorphisms between co-classified diseases implicate epistasis among noncoding elements. PACIFIC SYMPOSIUM ON BIOCOMPUTING 2018. 212669. ed. World Scientific Publishing Co. Pte Ltd, 2018. pp. 524-535
@inproceedings{10643c4067234a059474e67edba84714,
title = "Convergent downstream candidate mechanisms of independent intergenic polymorphisms between co-classified diseases implicate epistasis among noncoding elements",
abstract = "Eighty percent of DNA outside protein coding regions was shown biochemically functional by the ENCODE project, enabling studies of their interactions. Studies have since explored how convergent downstream mechanisms arise from independent genetic risks of one complex disease. However, the cross-talk and epistasis between intergenic risks associated with distinct complex diseases have not been comprehensively characterized. Our recent integrative genomic analysis unveiled downstream biological effectors of disease-specific polymorphisms buried in intergenic regions, and we then validated their genetic synergy and antagonism in distinct GWAS. We extend this approach to characterize convergent downstream candidate mechanisms of distinct intergenic SNPs across distinct diseases within the same clinical classification. We construct a multipartite network consisting of 467 diseases organized in 15 classes, 2,358 disease-associated SNPs, 6,301 SNP-associated mRNAs by eQTL, and mRNA annotations to 4,538 Gene Ontology mechanisms. Functional similarity between two SNPs (similar SNP pairs) is imputed using a nested information theoretic distance model for which p-values are assigned by conservative scale-free permutation of network edges without replacement (node degrees constant). At FDR≤5{\%}, we prioritized 3,870 intergenic SNP pairs associated, among which 755 are associated with distinct diseases sharing the same disease class, implicating 167 intergenic SNPs, 14 classes, 230 mRNAs, and 134 GO terms. Co-classified SNP pairs were more likely to be prioritized as compared to those of distinct classes confirming a noncoding genetic underpinning to clinical classification (odds ratio ~3.8; p≤10-25). The prioritized pairs were also enriched in regions bound to the same/interacting transcription factors and/or interacting in long-range chromatin interactions suggestive of epistasis (odds ratio ~ 2,500; p≤10-25). This prioritized network implicates complex epistasis between intergenic polymorphisms of co-classified diseases and offers a roadmap for a novel therapeutic paradigm: repositioning medications that target proteins within downstream mechanisms of intergenic disease-associated SNPs.",
keywords = "Biological similarity, Disease class, Enrichment, Intergenic, Noncoding, SNP",
author = "Jiali Han and Jianrong Li and Ikbel Achour and Lorenzo Pesce and Ian Foster and Haiquan Li and Lussier, {Yves A}",
year = "2018",
month = "1",
day = "1",
doi = "10.1142/9789813235533_0048",
language = "English (US)",
isbn = "9789813235533",
pages = "524--535",
booktitle = "PACIFIC SYMPOSIUM ON BIOCOMPUTING 2018",
publisher = "World Scientific Publishing Co. Pte Ltd",
address = "Singapore",
edition = "212669",

}

TY - GEN

T1 - Convergent downstream candidate mechanisms of independent intergenic polymorphisms between co-classified diseases implicate epistasis among noncoding elements

AU - Han, Jiali

AU - Li, Jianrong

AU - Achour, Ikbel

AU - Pesce, Lorenzo

AU - Foster, Ian

AU - Li, Haiquan

AU - Lussier, Yves A

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Eighty percent of DNA outside protein coding regions was shown biochemically functional by the ENCODE project, enabling studies of their interactions. Studies have since explored how convergent downstream mechanisms arise from independent genetic risks of one complex disease. However, the cross-talk and epistasis between intergenic risks associated with distinct complex diseases have not been comprehensively characterized. Our recent integrative genomic analysis unveiled downstream biological effectors of disease-specific polymorphisms buried in intergenic regions, and we then validated their genetic synergy and antagonism in distinct GWAS. We extend this approach to characterize convergent downstream candidate mechanisms of distinct intergenic SNPs across distinct diseases within the same clinical classification. We construct a multipartite network consisting of 467 diseases organized in 15 classes, 2,358 disease-associated SNPs, 6,301 SNP-associated mRNAs by eQTL, and mRNA annotations to 4,538 Gene Ontology mechanisms. Functional similarity between two SNPs (similar SNP pairs) is imputed using a nested information theoretic distance model for which p-values are assigned by conservative scale-free permutation of network edges without replacement (node degrees constant). At FDR≤5%, we prioritized 3,870 intergenic SNP pairs associated, among which 755 are associated with distinct diseases sharing the same disease class, implicating 167 intergenic SNPs, 14 classes, 230 mRNAs, and 134 GO terms. Co-classified SNP pairs were more likely to be prioritized as compared to those of distinct classes confirming a noncoding genetic underpinning to clinical classification (odds ratio ~3.8; p≤10-25). The prioritized pairs were also enriched in regions bound to the same/interacting transcription factors and/or interacting in long-range chromatin interactions suggestive of epistasis (odds ratio ~ 2,500; p≤10-25). This prioritized network implicates complex epistasis between intergenic polymorphisms of co-classified diseases and offers a roadmap for a novel therapeutic paradigm: repositioning medications that target proteins within downstream mechanisms of intergenic disease-associated SNPs.

AB - Eighty percent of DNA outside protein coding regions was shown biochemically functional by the ENCODE project, enabling studies of their interactions. Studies have since explored how convergent downstream mechanisms arise from independent genetic risks of one complex disease. However, the cross-talk and epistasis between intergenic risks associated with distinct complex diseases have not been comprehensively characterized. Our recent integrative genomic analysis unveiled downstream biological effectors of disease-specific polymorphisms buried in intergenic regions, and we then validated their genetic synergy and antagonism in distinct GWAS. We extend this approach to characterize convergent downstream candidate mechanisms of distinct intergenic SNPs across distinct diseases within the same clinical classification. We construct a multipartite network consisting of 467 diseases organized in 15 classes, 2,358 disease-associated SNPs, 6,301 SNP-associated mRNAs by eQTL, and mRNA annotations to 4,538 Gene Ontology mechanisms. Functional similarity between two SNPs (similar SNP pairs) is imputed using a nested information theoretic distance model for which p-values are assigned by conservative scale-free permutation of network edges without replacement (node degrees constant). At FDR≤5%, we prioritized 3,870 intergenic SNP pairs associated, among which 755 are associated with distinct diseases sharing the same disease class, implicating 167 intergenic SNPs, 14 classes, 230 mRNAs, and 134 GO terms. Co-classified SNP pairs were more likely to be prioritized as compared to those of distinct classes confirming a noncoding genetic underpinning to clinical classification (odds ratio ~3.8; p≤10-25). The prioritized pairs were also enriched in regions bound to the same/interacting transcription factors and/or interacting in long-range chromatin interactions suggestive of epistasis (odds ratio ~ 2,500; p≤10-25). This prioritized network implicates complex epistasis between intergenic polymorphisms of co-classified diseases and offers a roadmap for a novel therapeutic paradigm: repositioning medications that target proteins within downstream mechanisms of intergenic disease-associated SNPs.

KW - Biological similarity

KW - Disease class

KW - Enrichment

KW - Intergenic

KW - Noncoding

KW - SNP

UR - http://www.scopus.com/inward/record.url?scp=85048510934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048510934&partnerID=8YFLogxK

U2 - 10.1142/9789813235533_0048

DO - 10.1142/9789813235533_0048

M3 - Conference contribution

SN - 9789813235533

SP - 524

EP - 535

BT - PACIFIC SYMPOSIUM ON BIOCOMPUTING 2018

PB - World Scientific Publishing Co. Pte Ltd

ER -